Comparison of body weight gain between control group and cigarette smoke exposed group mice. by Yue He (385239)

Subjects:

Metabolome data of the discovery cohort. by Feng Gao (3548)

“…The results showed that compared with HC, five metabolites, including DL-stachydrine, D-(+)-pipecolinic acid, furazolidone, L-arginine and 5α-dihydrotestosterone glucuronide were significantly elevated and one metabolite, prenylcysteine, was significantly decreased in the serum of OC, and that the increase in L-arginine and the decrease in prenylcysteine led to impaired urea cycling and a high risk of developing atherosclerosis, respectively. …”

Incorporation of ¹⁴C-palmitate and ¹⁴C-acetate into triacylglycerol in <i>M</i>. <i>abscessus</i> is increased by NMP. by Timilehin Faboro (20175963)

Parameters for the treadmill during the acclimatization period. by Wenbin Wu (292223)

Subjects:

Improvement effect of lactoferrin and Coenzyme Q10 on body composition of mice with sarcopenia. by Wenbin Wu (292223)

Subjects:

KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia. by Wenbin Wu (292223)

Subjects:

Effects of lactoferrin and Coenzyme Q10 on skeletal muscle of mice. by Wenbin Wu (292223)

Subjects:

Each group’s performance on behavioral tests. by Wenbin Wu (292223)

Subjects:

Parameters for the treadmill during the testing phase. by Wenbin Wu (292223)

Subjects:

Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. by Wenbin Wu (292223)

Subjects:

HE staining of the gastrocnemius muscle. by Wenbin Wu (292223)

Subjects:

qPCR verified the expression changes of GO and KEGG pathway enriched sarcopenia related DEGs. by Wenbin Wu (292223)

Subjects:

Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

Subjects:

Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions. by Jiefeng Zhao (9090305)

Subjects:

Comparison of the mean number of unique diagnoses per hospital admission, between 2000 and 2023, stratified by chapters of ICD-10. The table shows absolute and relative changes in... by Stuart A. Bowyer (21253319)